| Year | Speaker and Lecture Details |
|---|---|
| 2017 | Mark Schiffman, M.D., M.P.H. National Cancer Institute Changing Epidemiology of HPV and Cervical Cancer: From Etiology, to Validation of Prevention Methods, to Dissemination |
| 2016 | Michael Bracken, Ph.D., M.P.H., FACE. Yale School of Public Health Inefficiency and Waste in Biomedical Research: How Prevalent Is It, What Are Its Causes, and How Is It Prevented? |
|
2015 |
Shiriki K. Kumanyika, Ph.D., M.P.H. Perelman School of Medicine at the University of Pennsylvania Research Directions for Solving the Obesity Epidemic in High-Risk Populations |
|
2014 |
Moyses Szklo, M.D., Dr.P.H., M.P.H. Johns Hopkins University Bloomberg School of Public Health, Baltimore Epidemiology: Back to Translation |
| 2013 | Mitchell Gail, M.D., Ph.D. Division of Cancer Epidemiology & Genetics, National Cancer Institute Using Risk Models for Breast Cancer Prevention |
| 2012 | Lewis H. Kuller, M.D., Dr.P.H., University of Pittsburgh Graduate School of Public Health The Obesity Epidemic: Why Have We Failed? |
| 2011 | Jonathan Samet, M.D., Johns Hopkins University Bloomberg School of Public Health, Baltimore Big Epidemiology for Big Problems |
| 2010 | Julie E. Buring, Sc.D., Harvard Medical School, Boston What Do We Do When Studies Disagree? |
| 2009 | Leon Gordis, M.D., Dr.P.H., M.P.H., Johns Hopkins University, Baltimore Epidemiology at the Interface of Science, Policy, and Politics: Are New Directions Needed for Epidemiology Training Today? |
| 2008 | Alice S. Whittemore, Ph.D., Stanford University School of Medicine, California Personalizing Cancer Prevention |
| 2007 | Robert N. Hoover, M.D., Sc.D., The National Cancer Institute, NIH Hormones & Breast Cancer: Etiology vs. Ideology |
| 2006 | Steven N. Blair, P.E.D., The Cooper Institute, Texas Physical Inactivity: The Biggest Public Health Problem in the 21st Century |
| 2005 | Jo Ann Manson, M.D., Dr.P.H., Harvard Medical School, Boston Post-Menopausal: Can Divergent Findings from Clinical Trials and Observational Studies Be Reconciled? |
| 2004 | Elizabeth Barrett-Connor, M.D., University of California, San Diego Diversity, Body Size and Diabetes: Genetics Without Genotyping |
| 2003 | Jeremiah Stamler, M.D., Northwestern University Nutrition, Blood Pressure, Cholesterol and Low Risk |
| 2002 | Sir Richard Peto, F.R.S., University of Oxford, UK Halving Premature Death |
| 2001 | David L. DeMets, Ph.D., University of Wisconsin, Madison Managing and Monitoring Multicenter Clinical Trials: Who Is in Charge of What? |
| 2000 | Steven R. Cummings, M.D., FACP, University of California, San Francisco New Technology and a Two-Edged Sword: How Bone Densitometry Has Revolutionized and Impeded the Understanding and Prevention of Osteoporotic Fractures |
| 1999 | Walter C. Willett, M.D., Dr.P.H., Harvard Medical School, Boston Diet and Coronary Heart Disease: Have We Misled the Nation? |
| 1998 | Alfred Sommer, M.D., M.H.S., Johns Hopkins University School of Hygiene and Public Health, Baltimore Epidemiology in the Cause of Vitamin A: Science to Practice |
| 1997 | Jean W. MacCluer, Ph.D., University of Texas Health Science Center, San Antonio From Epidemiology to Gene Discovery: Finding Genes for Complex Diseases |
| 1996 | Joseph F. Fraumeni, Jr., M.D., Sc.M., Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute Epidemiology of Cancer: An Interdisciplinary Approach |
| 1995 | Charles H. Hennekens, M.D., Dr.P.H., John Snow Professor of Medicine and Ambulatory Care and Prevention, Harvard Medical School Aspirin in the Secondary and Primary Prevention of Cardiovascular Disease |
Search Sort
1